Report cover image

UAE Active Pharmaceutical Ingredients (API) Market, By API (Synthetic API, Biological API); By Manufacturer (Captive Manufacturers, Merchant Manufacturers); By API of Drug (Branded/Innovator Drugs, Generic Drugs); By Therapeutic Area (Cardiovascular Syste

Publisher BlueWeave Consulting
Published Aug 25, 2023
Length 200 Pages
SKU # BLWC18285285

Description

UAE Active Pharmaceutical Ingredients (API) Market, By API (Synthetic API, Biological API); By Manufacturer (Captive Manufacturers, Merchant Manufacturers); By API of Drug (Branded/Innovator Drugs, Generic Drugs); By Therapeutic Area (Cardiovascular System, Central Nervous System, Respiratory System, Oncology, Gastrointestinal System, Others); By Potency (Traditional API, HPAPI), Trend Analysis, Competitive Landscape & Forecast, 2019–2029


UAE Active Pharmaceutical Ingredients (API) Market Size Zooming More Than 7X to Touch USD 9 Billion by 2029

UAE active pharmaceutical ingredients (API) market is gaining traction because of the increasing demand for generic drugs and rising prevalence of chronic diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the UAE active pharmaceutical ingredients (API) market size at USD 1,264.75 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the UAE active pharmaceutical ingredients (API) market size to grow at a CAGR of 38.61% reaching a value of USD 8,967.75 million by 2029. The prevalence of chronic diseases is on the rise, and patients are increasingly demanding individualized treatment plans, which are two major growth reasons for the UAE active pharmaceutical ingredients (API) market. Additionally, it is projected that the development of novel drug delivery methods would have a substantial impact on the market expansion over the forecast period.

UAE Active Pharmaceutical Ingredients (API) Market – Overview

Active pharmaceutical ingredients (API) are chemically and physiologically active components of medications that have a direct impact on the treatment, mitigation, and prevention of illnesses. These are produced using both chemical and biological methods. Paracetamol in medications for pain treatment and atorvastatin in medications for decreasing cholesterol are two examples of active substances. Oncology, cardiology, CNS and neurology, orthopedics, pulmonology, gastroenterology, nephrology, ophthalmology, and endocrinology are just a few of the medical specialties where APIs are used in high-quality medications.

UAE Active Pharmaceutical Ingredients (API) Market

Segmental Information

UAE Active Pharmaceutical Ingredients (API) Market – By Manufacturer

Based on manufacturer, the UAE active pharmaceutical ingredients (API) market is segmented into captive manufacturers and merchant manufacturers. Captive manufacturers hold a larger market share owing to the expanding pharmaceutical manufacturing industry in the UAE and the establishment of manufacturing facilities in the country. Captive manufacturing allows manufacturers to attain higher privacy and physical and intellectual property protection. However, merchant manufacturers are growing at a high rate owing to the rising outsourcing due to the lower cost of manufacturing.

Impact of COVID-19 on UAE Active Pharmaceutical Ingredients (API) Market

The unprecedented COVID-19 outbreak presented lucrative growth opportunities to the UAE active pharmaceutical ingredients (API) market. The pharmaceutical sector had a key role in treating COVID-19 symptoms such as high fever, cough, and cold. The active pharmaceutical components market expanded during the pandemic as a result of the pharma sector's exponential growth. After the COVID-19 outbreak was classified as a pandemic by the World Health Organization (WHO), a wide range of known pharmaceutical and biopharmaceutical businesses as well as new startups rushed up to develop treatments for the virus.

Competitive Landscape

Major players operating in the UAE active pharmaceutical ingredients (API) market include Teva Pharmaceutical Industries Ltd., Pfizer Inc., Novartis International AG, Mylan N.V., Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories Ltd, Merck & Co., Inc., and Lonza Group Ltd.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the UAE Active Pharmaceutical Ingredients (API) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the UAE Active Pharmaceutical Ingredients (API) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

200 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. UAE Active Pharmaceutical Ingredients (API) Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing Demand for Generic Drugs
3.2.1.2. Rising Prevalence of Chronic Diseases
3.2.2. Restrains
3.2.2.1. Price Volatility
3.2.3. Opportunities
3.2.3.1. Development of New Technologies
3.2.4. Challenges
3.2.4.1. Intense Competition
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. UAE Active Pharmaceutical Ingredients (API) Market Overview
4.1. Market Size & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By API
4.2.1.1. Synthetic API
4.2.1.2. Biological API
4.2.2. By Manufacturer
4.2.2.1. Captive Manufacturers
4.2.2.2. Merchant Manufacturers
4.2.3. By API of Drug
4.2.3.1. Branded/Innovator Drugs
4.2.3.2. Generic Drugs
4.2.4. By Therapeutic Area
4.2.4.1. Cardiovascular System
4.2.4.2. Central Nervous System
4.2.4.3. Respiratory System
4.2.4.4. Oncology
4.2.4.5. Gastrointestinal System
4.2.4.6. Others
4.2.5. By Potency
4.2.5.1. Traditional API
4.2.5.2. HPAPI
5. Competitive Landscape
5.1. List of Key Players and Their Offerings
5.2. UAE Active Pharmaceutical Ingredients (API) Company Market Share Analysis, 2022
5.3. Competitive Benchmarking, By Operating Parameters
5.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
6. Impact of Covid-19 on UAE Active Pharmaceutical Ingredients (API) Market
7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
7.1. Teva Pharmaceutical Industries Ltd
7.2. Pfizer Inc.
7.3. Novartis International AG
7.4. Mylan N.V.
7.5. Aurobindo Pharma Ltd
7.6. Sun Pharmaceutical Industries Ltd
7.7. Boehringer Ingelheim GmbH
7.8. Dr. Reddy's Laboratories Ltd
7.9. Merck & Co., Inc.
7.10. Lonza Group Ltd
7.11. Other Prominent Players
8. Key Strategic Recommendations
9. Research Methodology
9.1. Qualitative Research
9.1.1. Primary & Secondary Research
9.2. Quantitative Research
9.3. Market Breakdown & Data Triangulation
9.3.1. Secondary Research
9.3.2. Primary Research
9.4. Breakdown of Primary Research Respondents, By Region
9.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.
List of Figures
Figure 1 UAE Active Pharmaceutical Ingredients (API) Segmentation
Figure 2 UAE Active Pharmaceutical Ingredients (API) Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 UAE Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Million), 2019–2029
Figure 5 UAE Active Pharmaceutical Ingredients (API) Market Share, By API, By Value, 2019–2029
Figure 6 UAE Active Pharmaceutical Ingredients (API) Market Share, By Manufacturer, By Value, 2019–2029
Figure 7 UAE Active Pharmaceutical Ingredients (API) Market Share, By Type of Drug, By Value, 2019–2029
Figure 8 UAE Active Pharmaceutical Ingredients (API) Market Share, By Therapeutic Area, By Value, 2019–2029
Figure 9 UAE Active Pharmaceutical Ingredients (API) Market Share, By Potency, By Value, 2019–2029
List of Tables
Table 1 UAE Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Million), 2019–2029
Table 2 UAE Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019–2029
Table 3 UAE Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019–2029
Table 4 UAE Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019–2029
Table 5 UAE Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019–2029
Table 6 UAE Active Pharmaceutical Ingredients (API) Market Size, By Potency, By Value, 2019–2029
Table 7 Teva Pharmaceutical Industries Ltd Company Overview
Table 8 Teva Pharmaceutical Industries Ltd Financial Overview
Table 9 Pfizer Inc. Company Overview
Table 10 Pfizer Inc. Financial Overview
Table 11 Novartis International AG Company Overview
Table 12 Novartis International AG Financial Overview
Table 13 Mylan N.V. Company Overview
Table 14 Mylan N.V. Financial Overview
Table 15 Aurobindo Pharma Ltd Company Overview
Table 16 Aurobindo Pharma Ltd Financial Overview
Table 17 Sun Pharmaceutical Industries Ltd Company Overview
Table 18 Sun Pharmaceutical Industries Ltd Financial Overview
Table 19 Boehringer Ingelheim GmbH Company Overview
Table 20 Boehringer Ingelheim GmbH Financial Overview
Table 21 Dr. Reddy's Laboratories Ltd Company Overview
Table 22 Dr. Reddy's Laboratories Ltd Financial Overview
Table 23 Merck & Co., Inc. Company Overview
Table 24 Merck & Co., Inc. Financial Overview
Table 25 Lonza Group Ltd Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us